共 827 条
[1]
McMurray JJ(2012)ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC Eur Heart J 33 1787-1847
[2]
Adamopoulos S(2008)In vivo models for heart failure research In Vivo. 22 767-780
[3]
Anker SD(2017)Muscle wasting and cachexia in heart failure: mechanisms and therapies Nat Rev Cardiol 14 323-341
[4]
Auricchio A(1997)Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia Circulation. 96 526-534
[5]
Bohm M(2005)Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches Curr Heart Fail Rep. 2 198-203
[6]
Dickstein K(2013)Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF) Eur Heart J 34 512-519
[7]
Halapas A(1999)Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure Eur Heart J 20 683-693
[8]
Papalois A(2005)Relationship between exercise intolerance and levels of neurohormonal factors and proinflammatory cytokines in patients with stable chronic heart failure Int Heart J 46 1049-1059
[9]
Stauropoulou A(2013)Exercise intolerance in chronic heart failure--skeletal muscle dysfunction and potential therapies Circ J 77 293-300
[10]
Philippou A(2020)Cardiac cachexia revisited: the role of wasting in heart failure Heart Fail Clin 16 61-69